Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Office-based Methadone Versus Buprenorphine for Opioid Use Disorder
NCT06323824Phase 4Recruiting
- Sponsor
- Yale University
- Start
- Jun 2024
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methadone, buprenorphine extended-release injection in opioid use disorder (OUD), sponsored by Yale University. Started Jun 2024; status: recruiting.
02
Drugs
methadonebuprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06323824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06323824.